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Abstract 
Although the lung is the primary site of infection of tuberculosis, Mycobacterium tuberculosis is capable of caus-
ing infection at other sites. In 5–10 % such extra-pulmonary tuberculosis is located in bone tissue of the spine. It is 
unknown whether host or microbial factors are responsible for the site where extra-pulmonary tuberculosis manifests 
itself. One MDR isolate belonging to strain F28, one susceptible F11 and one isolate each of susceptible, MDR and XDR 
F15/LAM4/KZN were cultured in Middlebrook 7H9 media. Human osteoblasts (SaOS-2) and human alveolar epithelial 
cells (A549) were exposed to these different isolates of M. tuberculosis and invasion capacity and intra-cellular multipli-
cation rates were established. Mouse macrophage (MHS) cells exposed to M. tuberculosis H37Rv served as control. The 
invasion capacity of F15/LAM4/KZN representatives increased with the level of resistance. The F28 MDR strain showed 
similar invasion capacity as the XDR F15/LAM4/KZN for pulmonary epthelial cells, whilst the fully susceptible F11 
strain displayed a propensity for osteoblasts. The differences observed may in part explain why certain strains are able 
to cause infection at specific extra-pulmonary sites. We postulated that the development of extra-pulmonary tubercu-
losis depends on the ability of the microbe to pass effectively through the alveolar epithelial lining and its affinity for 
cells other than those in pulmonary tissue.
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Background
Tuberculosis (TB) is one of the most important causes of 
morbidity and mortality in the world (Supply et al. 2001). 
Although drug susceptible TB is a curable disease, it is 
considered a global public health problem in developing 
countries (Dye et  al. 1999). Worldwide, approximately 
nine million new TB cases and 1.6 million deaths occur 
annually (WHO 2012; Adlakha et  al. 2012). Mycobacte-
rium tuberculosis is the causative agent of TB. It is a fac-
ultative intracellular bacteria that begins the disease in 
the lung after inhalation of bacilli (Dannenberg 1982). 
Once infection is established, dissemination of the bacilli 
from the lung into the lymphatics or blood occurs result-
ing in spread of the infection to other part of the lungs 
and also to other organ systems (Dannenberg 1982). 
Macrophages are thought to be the principal host cell 
(Geiser 2002) which carry the bacilli from the alveolar 
space into interstitium and bloodstream (Bermudez et al. 
2002). However, since there is a predominance of epithe-
lial cells in the lung (Crandall and Kim 1991) these cells 
may be the first barrier that the organism faces (Adlakha 
et al. 2012). Earlier studies reported that M. tuberculosis 
adheres, invades and replicates within pulmonary epi-
thelial cells (Ashiru et al. 2010; Bermudez and Goodman 
1996; Mehta et  al. 1996). While the lung is the primary 
site of infection, M. tuberculosis can establish infection 
in virtually any other organ of the body, known as extra-
pulmonary tuberculosis. Patients co-infected with HIV 
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show a four-fold higher risk of extra-pulmonary tubercu-
losis (Kruijshaar and Abubakar 2009). Globally extra-pul-
monary tuberculosis accounts for 1–5 % of all TB cases 
but in South Africa 15 % of all recent cases of TB were 
extrapulmonary (WHO 2012; Trecarichi et al. 2012).
Osteoblasts originate from the mesenchymal stem cell 
(Stein et al. 1990; Gandhi et al. 2013). They play a major 
role in synthesis of bone matrix and regulate the activ-
ity of osteoclasts (Gay et al. 2000). It has been reported 
that Staphylococcus aureus and M. tuberculosis, which 
are common etiological agents of osteoarticular infec-
tions, can infect human osteoblasts in vitro (Jevon et al. 
1999; Wright and Friedland 2002). Spinal tuberculosis 
(Pott’s disease) is one of the most devastating, destructive 
and frequently encountered extrapulmonary forms of the 
disease. It is characterized by chronic inflammation with 
massive bone destruction of the spinal vertebrae, causing 
fracture and collapse of the vertebrae, ultimately resulting 
in compression of the spinal column with risk of paralysis 
and neurological deficits (Hoshino et al. 2014).
It is unknown what role host and microbial factors 
play in the development of Pott’s disease and how this 
compares to pulmonary infection. Approximately 20  % 
of patients with pulmonary TB develop extra pulmo-
nary infections and 60–75  % of patients with spinal TB 
have active or latent pulmonary tuberculosis (Garg and 
Somvanshi 2011). According to Herath et  al., the glob-
ally reported prevalence of extra-pulmonary tuberculo-
sis ranges from 17 to 52 %, with concurrent pulmonary 
involvement in up to 14 % (Herath and Lewis 2014).
The F15/LAM4/KZN genotype, first reported in the 
province of KwaZulu-Natal in the early 1990s, has devel-
oped into a family of closely related strains accompanied 
by progression from drug susceptible and multidrug-
resistant (MDR) to extensively drug-resistant (XDR) (Pillay 
and Sturm 2007). This genotype has been associated with 
the largest outbreak of XDR TB reported globally (Gan-
dhi et  al. 2013; Pillay and Sturm 2007). The rapid spread 
of this strain with concomitant high mortality among HIV-
infected patients in the Tugela Ferry region of KwaZulu-
Natal province (Gandhi et  al. 2006) suggests increased 
virulence. Other successful M. tuberculosis strain families 
are F11 and F28, which were found in more than 70 % of 
cases of drug-resistant TB in the rural regions of Boland-
Overberg and Southern Cape-Karoo of the Western Cape 
Province in South Africa (Streicher et  al. 2004). F11 is 
present in 21.4  % of all infected patients in the Western 
Cape communities, and is therefore at least as successful 
as the Beijing genotype which is responsible for 16.5 % of 
cases (Streicher et al. 2004; Victor et al. 2004). Among the 
patients with TB from the urban communities in Cape 
Town, the F28 strain causes disease in 9.7  % of cases. 
This strain family has not been reported from other parts 
of South Africa or other regions of Africa. Although F28 
appears to be common in the Western Cape Province, 
comparison of the IS6110-RFLP and the international 
RIVM spoligotype database suggests that this family may 
be more wide spread globally than previously thought.
To determine whether F15/LAM4/KZN, F28 and F11 
families of M. tuberculosis have a specific affinity for bone 
cells, we studied invasion and intracellular multiplication 
of pulmonary isolates of these strains in human osteoblasts 
(SaOS-2) and compared this with invasion and multi-
plication in pulmonary epithelial cells (A549) and alveo-
lar macrophages (MHS). We also addressed the question 
whether affinity for osteoblasts in F15/LAM4/KZN strains 
increased in parallel with development of resistance by 
including susceptible, MDR, and XDR representatives.
Methods
Mycobacterium tuberculosis isolates and growth condition
The M. tuberculosis isolates used in this study were 
retrieved from the culture collection in the Department 
of Infection Prevention and Control, Nelson R Mandela 
School of Medicine, School of Laboratory Medicine and 
Medical Science, College of Health Sciences, University 
of KwaZulu-Natal. Three of these belonged to the F15/
LAM4/KZN (KZN) family of which one was fully sus-
ceptible, one MDR and one XDR. One susceptible isolate 
belonged to the F11 and one MDR isolate to the F28 fam-
ily (see Table 1). Laboratory strain H37Rv (ATCC 27294) 
was included for reference purposes. The isolates were 
cultured for approximately 3  weeks at 37  °C in a shak-
ing incubator in Middlebrook 7H9 broth, supplemented 
with 10 % oleic acid, albumin, dextrose, catalase (OADC), 
0.05 % Tween 80 and 0.5 % glycerol.
Inocula preparation
Cultures were harvested and single cell suspensions were 
obtained as previously described (Ashiru et  al. 2010). 
Table 1 Description of  different clinical isolates of  Myco-
bacterium tuberculosis used in  the experiments (suscep-
tible; MDR: multi-drug resistant; XDR: extensively drug 
resistant)
I isoniazid, R rifampin, E ethambutol, P pyrazinamide, S streptomycin, Eth 
ethionamide, A amikacin, C capreomycin, K kanamycin, O ofloxacin
Mycobacterium tuberculosis 
family
Strain number Resistant to
F15/LAM4/KZN V4027 _
F15/LAM4/KZN MODS 688 I, R, E, P
F15/LAM4/KZN MODS 388 I, R, E, P, S, Eth, A, C, K, O
F28 TF 44949 I, R, E, P
LAM3/F11 TF 832 _
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Briefly, vortex agitated suspensions were allowed to stand 
at room temperature for 15 min. Thereafter, the top 6 ml 
was forced 10 times up and down through a 26 gauge 
needle and then filtered using a 5 µm Millipore filter. To 
determine the number of colony forming units (CFU) 
per ml, volumes of 10 µl of suspensions with optical den-
sity at 600 nm (OD 600) of 1 were plated in triplicate on 
OADC enriched Middlebrook 7H11 agar media (Difco).
Cell lines
Three different cell lines were used for the experiments. 
A549 human type II alveolar epithelial cells (ATCC-
CCL185) were cultured in EMEM medium containing 
25  mM of HEPES, 10  % heat-inactivated fetal bovine 
serum (FBS), 2 mM of l-glutamine; MH-S murine alve-
olar macrophage cells (ATCCCRL2019) in RPMI-1640 
medium containing 25 mM of HEPES, 10 % FBS, 2 mM 
of l-glutamine and SaOS-2 human osteoblast cells 
(ATCC HTB-85) were grown McCoy’s 5a medium with 
15 % FBS. Semi-confluent monolayers were detached by 
trypsinization using trypsine-versene (Cambrex BioSci-
ence). Trypan blue exclusion was used to determine the 
number of viable cells using a haemocytometer and 1 ml 
of the cell suspensions containing 1  ×  105 viable cells/
ml were seeded into each well of a 24-well tissue culture 
plate. Experiments were done with A549 and MHS cells 
incubated for ±48 h at 37 °C in 5 % CO2 atmosphere at 
>90 % confluency, whereas SaOS-2 cells were incubated 
similarly for 72 h.
Invasion and multiplication assay
Bacterial invasion was studied as described before 
(Ashiru et  al. 2010) with modifications. Cells were 
washed thrice with phosphate buffered saline (PBS pH 
7.3; Oxoid) maintained at room temperature, after which 
1  ml cell-specific culture medium (maintained at room 
temperature) was added to each well. Following inocu-
lation of the cells with the M. tuberculosis suspension at 
a multiplicity of infection (MOI) of 9-12 per cell, plates 
were incubated for 2 h at 37 °C.
To kill extracellular bacteria, aminoglycoside protec-
tion assays were performed. This involved exposing the 
inoculated cells to media containing amikacin (200  µg/
ml) for 1 h. This concentration of amikacin was used after 
susceptibility screening had been carried out. Briefly, 
standardized M. tuberculosis inoculum was prepared in 
volumes of 1 ml as mentioned above using isolates with 
different susceptibility profiles (susceptible, MDR and 
XDR) and H37Rv. Each suspension was centrifuged at 
3000×g for 20 min. The supernatants were discarded and 
replaced with 1 ml of media containing different concen-
trations of amikacin (20, 30, 40 and 50 µg/ml). This was 
followed by brief vortex agitation to resuspend the bacilli 
and thereafter, the bacterial suspensions were incubated 
for 1  h at 37  °C and plated onto OADC enriched Mid-
dlebrook 7H11 agar plates in triplicate and incubated for 
3 weeks to determine the CFU per ml.
After the aminoglycoside protection assay, the cells 
were washed thrice with PBS, pH 7.3 to remove the ami-
kacin and then lysed with 1 ml of 0.1 % Triton X-100 in 
distilled water for 20 min. The spent culture medium was 
plated on OADC enriched Middlebrook 7H11 agarplates 
and incubated for 3 weeks to check whether all extracel-
lular bacteria were killed. Serial ten-fold dilutions of the 
lysate were prepared in Middlebrook 7H9 broth with 
0.05 % Tween −80 and plated on OADC enriched Mid-
dlebrook 7H11 agar medium. The plates were incubated 
for 3 weeks in sealed CO2 permeable plastic bags at 37 °C 
and the percentage of bacterial invasion was determined 
based on the obtained colony counts.
To measure intra-cellular multiplication, separate wells 
with amikacin treated inoculated cells were further incu-
bated in their specific growth media at 37 °C in 5 % CO2 
atmosphere for different time periods. After specific time 
points (24, 48 and 72 h), the overlaying growth medium 
was removed and the infected cell monolayers were 
washed with PBS and lysed as described above. Ten-fold 
serial dilutions of the lysates were plated in triplicate on 
OADC enriched 7H11 plates and incubated for 3 weeks 
for viable count analysis.
Statistical analysis
All data were analysed by one-way ANOVA (Post Hoc 
Test: Tukey HSD by means of SPSS software) or student t 
test. In all cases significance was accepted at P < 0.05.
Ethics approval
The study was approved by the Biomedical Research Eth-
ics Committee of the University of KwaZulu-Natal (Ref-
erence no: BCA274/09).
Results
Invasion of Mycobacterium tuberculosis of osteoblasts 
and alveolar cell lines
No growth was observed following exposure of M. 
tuberculosis isolates to 30, 40 and 50  µg/ml of amika-
cin respectively including the XDR isolates. There was 
also no growth from the discarded media following the 
amikacin protection assay. This further confirmed that 
only internalized bacilli were reported. The amikacin 
concentration of 200 µg/ml used in this aminoglycoside 
protection assay is 100 times higher than the recom-
mended breakpoint for resistance and 10 times higher 
than the reported concentration that killed extracellular 
bacilli (Ashiru et al. 2010) and this also kills XDR isolates 
(WHO 2009).
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Figure  1 shows the invasion capacity of the differ-
ent isolates in the three cell lines. Based on the invasion 
capacity into the human osteoblast SaOS-2 cells, two 
groups of three isolates each could be distinguished. The 
MDR F28 and drug susceptible KZN isolates grouped 
together with H37Rv, displaying significantly lower inva-
sion capacity as compared to the second group which 
included the drug susceptible F11 and the MDR as well as 
XDR representative of the KZN strain (P ≤ 0.001).
In A549 alveolar epthelial cells, the XDR KZN and the 
MDR F28 isolates showed almost equal invasion lev-
els (P  >  0.05) and these were significantly higher than 
those of the susceptible KZN and the susceptible F11 
isolates as well as H37Rv (P  ≤  0.001). The MDR KZN 
isolate featured in between with no significant differ-
ence with either of those two groups (P  <  0.05). H37Rv 
invaded the mouse alveolar macrophage cell line MHS at 
levels reported by others (Liu et al. 2013; Sirakova et al. 
2003). Like in alveolar epthelial cells, invasion capac-
ity into MHS alveolar macrophages was highest for the 
XDR KZN and MDR F28 isolates and the difference with 
the other isolates was statistically significant (P ≤ 0.001). 
Drug susceptible F11 and both the drug susceptible KZN 
and MDR KZN isolates, showed similar invasion capacity 
as H37Rv. Between the two alveolar cell lines, invasion of 
MHS cells was higher for all isolates (P ≤ 0.008).
Intra‑cellular multiplication of Mycobacterium tuberculosis
Intracellular multiplication in bone cells and alveolar cells 
differed between isolates. In SaOS-2 cells the drug sus-
ceptible F11 and both the MDR and XDR KZN isolates 
showed the same multiplication pattern. The intracellular 
number of organisms increased over time at similar rates 
up to 48  h, with significantly higher number of organ-
isms present at each time point as compared with the 
other isolates. The calculated growth rate was 0.62 × per 
12 h. Between 48 and 72 h, the F11 and XDR KZN iso-
lates kept multiplying with a growth rate of 0.75 ×  per 
12 h and 0.83 × per 12 h respectively, but the MDR KZN 
growth rate became negative (−0.35 × per 12 h) in that 
time period. The drug susceptible KZN and MDR F28 
isolates showed a multiplication rate of 0.81 × per 12 h 
between 2 and 48 h but growth of H37Rv became nega-
tive in the last 24 h (Fig. 2a).
In A549 cells, the intracellular number of organisms of the 
XDR KZN and drug susceptible KZN isolates increased at 
similar rate (0.69 × per 12 h) up to 48 h and after that time 
point XDR KZN isolates showed a progressive increase with 
a multiplication rate of 0.77 × per 12 h from the 48-h time 
point to 72 h of incubation. The growth rate of the drug sus-
ceptible KZN isolate became negative (−0.33 × per 12 h) 
in that time period. After 24 h, MDR F28 and drug suscep-
tible F11 isolates exhibited a similar multiplication pattern 
with negative growth rate (−0.2 × per 12 h) from 48 to 72 h. 
Multiplication of the MDR KZN isolate stopped after 24 h 
and consequently over the next 48 h the number of organ-
isms remained stable. Multiplication of H37Rv was signifi-
cantly slower than any of the clinical isolates during the 72 h 
of incubation (Fig. 2b).
Intracellular multiplication in alveolar macrophages 
differed between isolates. In MHS cells the drug suscep-
tible F11 and both the drug susceptible KZN and MDR 
KZN isolates showed the same multiplication pattern. 
After initial entry, the intracellular number of organ-
isms of all three isolates displayed a slow growth rate 
(both KZN isolates) or numbers remained stable (F11) 
up to 24 h and then increased up to 72 h. The calculated 
growth rate during that period was 0.72 × per 12 h. The 
MDR F28 isolates showed a decrease in numbers during 
the first 24  h but then started to increase at a multipli-
cation rate of 0.73 × per 12 h between 24 and 72 h. At 
each time point a significantly (P ≤ 0.001) higher number 
of organisms of the XDR KZN isolate was present when 
compared to the other isolates. The calculated growth 
rate was 0.54 ×  per 12  h between 24 and 72  h. H37Rv 
displayed a slow growth rate up to 48  h with accelera-
tion in the last 24 h. This was comparable with F11 and 
the susceptible and MDR-KZN isolates but significantly 
(P  <  0.05) lower compared to XDR KZN or MDR F28 
(Fig. 2c).
Discussion
Extra-pulmonary tuberculosis occurs in any part of the 
body. The port of entry for M. tuberculosis is the lung. 




































Fig. 1 Comparison of the invasion capacity of different strains of 
Mycobacterium tuberculosis within human osteoblasts (SaOS-2) cells, 
epithelial cells (A549) and murine alveolar macrophages (MHS) at 
MOI 9-12. After 2 h of infection cells were incubated with antibiotics 
to kill extracellular bacteria. Cells were lysed and plated on 7H11 agar 
to determine intracellular CFU. Data are the mean (±SD) of three 
separate experiments. Different superscripts in different cell lines are 
indication of significance (P < 0.05)
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Spread through the body is thought to occur by transport 
inside migrating macrophages as well as through bacte-
raemia (Dannenberg and Rook 1994; Edwards and Kirk-
patrick 1986). The site where the bacteria settle and later 
on develop extra-pulmonary tuberculosis was thought to 
be random. However, some recent studies reported asso-
ciations between M. tuberculosis strains and site of extra-
pulmonary disease (Adlakha et  al. 2012; Be et  al. 2012; 
Caws et  al. 2008; Click et  al. 2012; Garcia de Viedma 
2003; Hernandez Pando et al. 2010; Lari et al. 2009). We 
postulated that the development of extra-pulmonary 
tuberculosis depends on the ability of the microbe to 
pass effectively through the alveolar epithelial lining and 
its affinity for cells other than those in pulmonary tis-
sue. Since Pott’s disease is a frequently diagnosed form 
of extra-pulmonary tuberculosis, we chose human oste-
oblasts as the extra-pulmonary cell type. Hoshino et  al. 
(2014) reported that M. tuberculosis strains can multiply 
in bone cells. However, they used osteoclasts in stead 
of osteoblasts. We chose osteoblasts based on the find-
ings of Wright and Friedland (2002) who reported that in 
these cells the production of pro-inflammatory cytokines 
is upregulated when infected with M. tuberculosis or S. 
aureus. It is therefore likely that osteoblasts are essential 
in the development of Pott’s disease.
The MHS mouse macrophage cell line exposed to M. 
tuberculosis H37Rv served as control. We found that 
there are indeed major differences between the strains of 
M. tuberculosis. Based on former work in our laboratory 
with A549 cells in which we found differences between 
F15/LAM4/KZN isolates, we also included isolates of 
this strain with different resistance profiles (Ashiru et al. 
2010).
Our results indicate that there are differences in inva-
sion and intracellular multiplication between strains in 
alveolar epithelium and that for F15/LAM4/KZN inva-
sion capacity increases with the level of resistance. Of the 
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Fig. 2 Intracellular growth of different Mycobacterium tuberculosis strains within a human osteoblasts (SaOS-2) cells, b human epithelial cells (A549) 
and c murine alveolar macrophages (MHS). After infection at MOI 9-12, cells were incubated with antibiotics to kill extracellular bacteria. Cells were 
further cultured in their specific media on 37 °C in 5 % CO2 atmosphere for different time hours to see the growth of different strains in different 
cell types. After specific time points cells were lysed and plated on 7H11 agar to determine intracellular CFU/ml. Data are the mean (±SD) of three 
separate experiments. (*) Indicates significant value (P < 0.05)
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invasion capacity as the XDR F15/LAM4/KZN. Whether 
this is related to the fact that the F28 isolate used had 
the MDR resistance profile needs further investigation. 
The observations with the osteoblast cell line differed in 
that now, the fully susceptible F11 isolate was the most 
invasive strain. Interestingly, while the susceptible F15/
LAM4/KZN isolate’s invasion capacity in osteoblasts was 
low and comparable with H37Rv, the MDR and XDR iso-
lates of this strain invaded at a much higher rate. Simi-
larly, both resistant isolates of F15/LAM4/KZN showed a 
significantly higher multiplication rate in these cells. We 
conclude that in parallel to the development to MDR, a 
genetic event occurred that increased the affinity of the 
strain to bone tissue. This needs further exploration.
We explained the difference in the number of intracel-
lular organisms between the isolates by differences in 
multiplication rate. We considered the possibility that 
the isolates with lower intracellular numbers were cyto-
toxic and therefore had fewer or less viable cells available. 
Although we did not test for cytotoxicity, this explanation 
seems unlikely since we did not observe any microscopic 
differences between the SaOS-2 cells exposed to the dif-
ferent isolates.
Passing of the mycobacteria through lung tissue into 
other parts of the body can be through transepithelial 
migration (Birkness et al. 1999) or through destruction of 
lung tissue (Danelishvili et  al. 2003). Whether transepi-
thelial migration occurs needs to be investigated. How-
ever, we do have evidence that cytoxic effect on A549 
cells is highest in resistant isolates of F15/LAM4/KZN 
(Ashiru and Sturm 2015).
Most studies on interaction of Mycobacterium tubercu-
losis with alveolar cell types involve alveolar macrophages 
(Crouch et  al. 2000; McCormack and Whitsett 2002). 
These large pleomorphic cells are found within lung alve-
oli as free cells or attached to the respiratory epithelium 
and are classically thought to be the first cell to respond 
to inhaled pathogens (Geiser 2002; Crouch et  al. 2000; 
McCormack and Whitsett 2002). MHS cells are a use-
ful model for the in vitro study of alveolar macrophages. 
Like in primary alveolar macrophages, Mycobacterium 
tuberculosis survives in MHS cells after infection (Melo 
and Stokes 2000). Our findings are in agreement with 
previous studies that Mycobacterium tuberculosis strains 
invade both A549 and MHS cells. However our results 
revealed that different strains showed distinct invasion 
capacity for different cell types and in general invasion 
capacity in MHS cells was higher compared to A549. 
This is similar with the findings of Mehta et  al. (1996) 
who reported that in the epithelial cells bacterial uptake 
may be at a lower rate compared with macrophages 
(Mehta et al. 1996). The contribution of invasion of each 
of these alveolar cell types in the further development 
to extra-pulmonary tuberculosis needs additional 
investigations.
Conclusion
It has been previously assumed that the site of extra-
pulmonary tuberculosis (EPT) in individual patients 
was an event likely to be random, or at most influenced 
by host factors only. Recently, there is accumulating evi-
dence that shows significant differences between strains 
of Mycobacterium tuberculosis. In this paper we postu-
lated that the site of EPT was at least partly determined 
by bacterial characteristics.
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